MUC1 and breast cancer: The antibodies produced upon immunization with 16 bound to MUC1-Tn-positive T47D human breast cancer cells.Furthermore, the antibody selectivity was assessed via glycopeptidemicroarray binding assays, which revealed that the presence of glycocluster 1 did not alter the recognition pattern of the antibodies.